A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2002
08/08/2002	WO2002060412A2 Stabilised polymeric aerosols for pulmonary gene delivery
08/08/2002	WO2002060411A2 Process for production of nanoparticles and microparticles by spray freezing into liquid
08/08/2002	WO2002060406A2 Veterinary dermatologic composition
08/08/2002	WO2002060405A1 Veterinary dermatologic composition comprising a sphingoid base and/or a sphingoid base derivative
08/08/2002	WO2002060393A2 Proteoglycan compositions for treatment of inflammatory conditions
08/08/2002	WO2002060392A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
08/08/2002	WO2002060389A2 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
08/08/2002	WO2002060388A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
08/08/2002	WO2002060387A2 Use of prostaglandin analogs for treatment of cardiac conditions
08/08/2002	WO2002060386A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
08/08/2002	WO2002060383A2 Cancer therapy
08/08/2002	WO2002060382A2 Novel compounds and uses thereof
08/08/2002	WO2002060381A2 Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function
08/08/2002	WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use
08/08/2002	WO2002060375A2 Diphenyl ether derivatives and their uses as heparanase inhibitors
08/08/2002	WO2002060374A2 Benz-1,3-azole derivatives and their uses as heparanase inhibitors
08/08/2002	WO2002060373A2 Indole derivatives and their uses as heparanase inhibitors
08/08/2002	WO2002060341A2 Inhibition of proteasomes to prevent restenosis
08/08/2002	WO2002060340A2 Method for identifying maxi-k channel blockers
08/08/2002	WO2002060339A2 Ophthalmic compositions for treating ocular hypertension
08/08/2002	WO2002060279A1 $g(a)-lactalbumin as prebiotic agent
08/08/2002	WO2002060278A1 Food supplement with a slimming effect
08/08/2002	WO2002060276A1 Combination of probiotics
08/08/2002	WO2002060272A1 Anticholesterolemic edible oil
08/08/2002	WO2002060258A1 Fish anthelmintics and anthelmintic method
08/08/2002	WO2002060257A1 Pharmaceutical composition containing aminoacetonitril compounds and the use thereof for the preparation of a pharmaceutical composition for the treatment of endoparasitic pests in animals
08/08/2002	WO2002046241A3 Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
08/08/2002	WO2002045699A3 Transdermal therapeutic system comprising the active ingredient oxybutynin
08/08/2002	WO2002044142A3 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders
08/08/2002	WO2002040505A3 Dibenzoxazepine alpha v integrin receptor antagonist
08/08/2002	WO2002036094A3 Method and dermatological and/or cosmetic composition for inhibiting the adhesion effect of circulating cells
08/08/2002	WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity
08/08/2002	WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
08/08/2002	WO2002032409A3 Use of compound in the manufacture of a pharmaceutical for inhibiting steroid sulphatase and steroid dehydrogenase activity
08/08/2002	WO2002030455A3 Agents for the treatment of viral infections
08/08/2002	WO2002024690A8 Efficient process for the preparation of a factor xa inhibitor
08/08/2002	WO2002024650A3 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
08/08/2002	WO2002022175A3 Method and composition for treating tumors by selective induction of apoptosis
08/08/2002	WO2002022161A3 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases
08/08/2002	WO2002020762A3 Tnf receptor-like molecules and uses thereof
08/08/2002	WO2002019971A9 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
08/08/2002	WO2002018327A3 Guanidinobenzamides as mc4-r agonists
08/08/2002	WO2002017894A3 Pharmaceutical formulation of salmeterol and fluticasone propionate
08/08/2002	WO2002015722A3 Treatment of helicobacter with isothiocyanates
08/08/2002	WO2002015664A3 Methods of preventing or treating west nile virus and other infections
08/08/2002	WO2002014269A3 2,4-substituted pyridine derivatives
08/08/2002	WO2002011735A3 Association of a purine activity and a nonsteroidal anti-inflammatory anti-inflammatory drug for treating sexual dysfunction
08/08/2002	WO2002011665A3 Association of a purine and a nonsteroidal anti-inflammatory drug for treating sexual dysfunction
08/08/2002	WO2002010140A3 Imidazolyl derivatives
08/08/2002	WO2002009690A3 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
08/08/2002	WO2002007729A9 Non-sedating barbiturate compounds as neuroprotective agents
08/08/2002	WO2002006189A3 Aniline derivatives
08/08/2002	WO2002005851A3 Enhancement of the action of central and peripheral nervous system agents
08/08/2002	WO2002005801A3 Compositions containing diacyltartaric salts of (e)-metanicotine
08/08/2002	WO2002003993A3 Use of inhibitors to multidrug resistance protein 5 (mrp5) to enhance intracellular levels of cyclic nucleotides
08/08/2002	WO2002003986A3 Use of substituted indole compounds for treating breast disorders
08/08/2002	WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
08/08/2002	WO2002002518A3 Compounds to treat alzheimer's disease
08/08/2002	WO2002000631A3 Benzhydryl derivatives
08/08/2002	WO2002000194A3 Polymeric micelle compositions
08/08/2002	WO2002000170A3 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer
08/08/2002	WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity
08/08/2002	WO2001095899A3 Pharmaceutical compositions comprising cannabidiol derivatives
08/08/2002	WO2001094335A3 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor
08/08/2002	WO2001094312A3 Indolinone derivatives as protein kinase/phosphatase inhibitors
08/08/2002	WO2001093917A3 Preparation for breast duct fluid collection
08/08/2002	WO2001093840A3 Ligands of integrin receptors
08/08/2002	WO2001091814A3 Polyubiquitin based hydrogel and uses thereof
08/08/2002	WO2001091786A3 Diagnosis and treatment of herpes infections
08/08/2002	WO2001088101A3 CELL LINE FOR THE EXPRESSION OF AN α2δ2 CALCIUM CHANNEL SUBUNIT
08/08/2002	WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
08/08/2002	WO2001085926A3 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
08/08/2002	WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis
08/08/2002	WO2001085150A3 Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists
08/08/2002	WO2001082938A3 Compositions useful in the treatment of diseases of connective tissues comprising a ferrous ion and an ascorbate
08/08/2002	WO2001082918A9 Method for the prevention of apoptosis
08/08/2002	WO2001082908A3 Ginsenoside chemotherapy
08/08/2002	WO2001082907A3 Use of n-heterocyclic substituted salicylates for inhibition of cellular uptake of cystine
08/08/2002	WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec)
08/08/2002	WO2001081334A3 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands
08/08/2002	WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
08/08/2002	WO2001080895A3 Methods and compositions for the treatment of cardiac indications
08/08/2002	WO2001080890A3 Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
08/08/2002	WO2001077376A3 Diagnosis of diseases associated with metastasis
08/08/2002	WO2001076451A9 Diagnosis of diseases associated with metabolism
08/08/2002	WO2001070941A3 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
08/08/2002	WO2001070211A3 L-arginine and phosphodiesterase (pde) inhibitor synergism
08/08/2002	WO2001068117A3 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
08/08/2002	WO2001068116A3 Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections
08/08/2002	WO2001068103A3 Treatment of herpes infection using immunomodulatory polynucleotide sequences
08/08/2002	WO2001068077A3 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections
08/08/2002	WO2001064685A3 Thienopyridine derivatives and their use as anti-inflammatory agents
08/08/2002	WO2001059152A9 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
08/08/2002	WO2001056555A3 Use of cox-2 inhibitors for the treatment of constipation
08/08/2002	WO2001051073A9 The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
08/08/2002	WO2001048238A3 Chemotherapeutant screening method
08/08/2002	WO2001036419A9 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
08/08/2002	WO2001034802A9 Compositions and methods for the therapy and diagnosis of prostate cancer
08/08/2002	WO2001032925A9 Modulation of neuroendocrine differentiation by protein 25.1
08/08/2002	WO2001023604A3 Highly conserved genes and their use to generate probes and primers for detection of microorganisms

1 ... 5744 5745 5746 5747 5748 5749 5750 5751 5752 5753 5754 5755 5756 5757 5758 5759 5760 5761 5762 5763 5764 ... 7860